ClinicalTrials.Veeva

Menu
H

Hassman Research Institute | Marlton, NJ

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

KarXT
SEP-363856
BHV-7000
SP-624
BI 1569912
Ketamine
SEP363856
Aripiprazole
IkT-148009
Roluperidone

Parent organization

This site is a part of Hassman Research Institute

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 39 total trials
Locations recently updated

A Study to Test Different Doses of BI 1569912 in People With Depression Who Take Anti-depressive Medicine

This study is open to adults between 18 and 65 with a type of depression (major depressive disorder) for whom previous treatments for depression did...

Enrolling
Depressive Disorder, Major
Drug: BI 1569912
Drug: Placebo

The purpose of this study is to determine whether BHV-7000 is a safe and effective acute treatment for manic episodes in bipolar disorder I.

Enrolling
Bipolar Disorder
Drug: Placebo
Drug: BHV-7000

The purpose of this study is to evaluate the long-term safety and tolerability of BHV-7000 in subjects with bipolar I disorder.

Invitation-only
Bipolar Disorder
Drug: BHV-7000

Study of the contraceptive efficacy, cycle control, safety, and tolerability of MR-100A-01 in approxmiately 1200 women for up to 13 cycles

Active, not recruiting
Contraception
Drug: MR-100A-01

Trial sponsors

Otsuka logo
Boehringer Ingelheim logo
Karuna Therapeutics logo
Biohaven logo
Cerevel Therapeutics logo
E
Lilly logo
L
S
Viatris logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems